Practice Guideline
doi: 10.1164/rccm.168.7.818.
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
- PMID: 14522813
- DOI: 10.1164/rccm.168.7.818
Item in Clipboard
Practice Guideline
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
Am J Respir Crit Care Med.
.
No abstract available
Similar articles
-
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency].Pneumologie. 2005 Jan;59(1):36-68. doi: 10.1055/s-2004-830176. Pneumologie. 2005. PMID: 15685488 German. No abstract available.
-
Alpha1-antitrypsin deficiency: what's new after European Respiratory Society Statement.Panminerva Med. 2018 Sep;60(3):101-108. doi: 10.23736/S0031-0808.18.03450-X. Epub 2018 Apr 24. Panminerva Med. 2018. PMID: 29696962 Review.
-
Alpha-1-antitrypsin deficiency.Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):629-33. doi: 10.1016/j.bpg.2010.08.006. Best Pract Res Clin Gastroenterol. 2010. PMID: 20955965 Review.
-
Alpha-1-antitrypsin deficiency: diagnosis and treatment.Clin Liver Dis. 2004 Nov;8(4):839-59, viii-ix. doi: 10.1016/j.cld.2004.06.001. Clin Liver Dis. 2004. PMID: 15464658 Review.
-
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency.Eur Respir J. 2017 Nov 30;50(5):1700610. doi: 10.1183/13993003.00610-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29191952 Review.
Cited by
-
Higher healthcare cost and utilization before and after diagnosis of AATD in the United States.BMC Pulm Med. 2024 Nov 16;24(1):570. doi: 10.1186/s12890-024-03396-w. BMC Pulm Med. 2024. PMID: 39550556 Free PMC article.
-
Alpha-1 antitrypsin deficiency associated with rare SERPINA1 alleles p.(Phe76del) and p.(Asp280Val): A family study.Respir Med Case Rep. 2024 Aug 28;51:102097. doi: 10.1016/j.rmcr.2024.102097. eCollection 2024. Respir Med Case Rep. 2024. PMID: 39286412 Free PMC article.
-
Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential.Front Immunol. 2024 Aug 19;15:1443297. doi: 10.3389/fimmu.2024.1443297. eCollection 2024. Front Immunol. 2024. PMID: 39224588 Free PMC article. Review.
-
A rare AAT variant presenting in a COPD patient: Q0 amersfoort mutation.Respir Med Case Rep. 2024 Jul 5;51:102084. doi: 10.1016/j.rmcr.2024.102084. eCollection 2024. Respir Med Case Rep. 2024. PMID: 39092427 Free PMC article.
-
Assessing the efficacy of Alpha1-Proteinase inhibitor (human) augmentation therapy for Alpha1-Antitrypsin deficiency - Related emphysema: Challenges and opportunities.Heliyon. 2024 May 23;10(11):e31183. doi: 10.1016/j.heliyon.2024.e31183. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38912501 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
